immuneXcite

immuneXcite

immuneXcite

Biopharmaceuticals ImmuneXcite is a biopharmaceutical company focused on developing the next generation of monoclonal antibodies for cancer, employing....
Raised
$17.2M
Follow us
Alexa global traffic share
Team Size
1–10
Employees
$8,600,000 Venture capital (Series A)
FierceBiotech , ImmuneXcite

Sanofi Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round

Health Funding
$8,600,000 Venture capital (Series A)
FinSMEs , Xconomy

ImmuneXcite Completes $8.6M Series A-1 Financing

Health Funding